T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody. // Immunity. – URL: https://www.sciencedirect.com/science/article/pii/S1074761326004280?dgcid=rss_sd_all
T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody. Immunity. https://www.sciencedirect.com/science/article/pii/S1074761326004280?dgcid=rss_sd_all
“T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody.” Immunity.
@article{article4046,
title = {T cell cross-priming by PD-L1+ type 1 conventional dendritic cells mediates the antitumor efficacy of a PD-L1×4-1BB bispecific antibody},
journal = {Immunity},
url = {https://www.sciencedirect.com/science/article/pii/S1074761326004280?dgcid=rss_sd_all}
}